Thrive Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.15M Sell
2,717
-501
-16% -$200K 0.14% 76
2026
Q2
$1.17M Sell
3,218
-28
-0.9% -$9.6K 0.15% 72
2026
Q1
$1.14M Sell
3,246
-36
-1% -$12.8K 0.17% 64
2025
Q4
$1.07M Buy
3,282
+28
+0.9% +$8.88K 0.16% 71
2025
Q3
$918K Sell
3,254
-18
-0.6% -$5.22K 0.14% 84
2025
Q2
$914K Buy
3,272
+420
+15% +$119K 0.15% 84
2025
Q1
$889K Sell
2,852
-36
-1% -$10.6K 0.17% 80
2024
Q4
$753K Buy
2,888
+13
+0.5% +$3.86K 0.14% 87
2024
Q3
$926K Buy
2,875
+21
+0.7% +$6.87K 0.17% 77
2024
Q2
$892K Buy
2,854
+82
+3% +$24.1K 0.17% 70
2024
Q1
$788K Buy
2,772
+436
+19% +$128K 0.16% 80
2023
Q4
$673K Buy
2,336
+1
+0% +$272 0.15% 86
2023
Q3
$628K Buy
2,335
+187
+9% +$46.7K 0.17% 83
2023
Q2
$477K Sell
2,148
-123
-5% -$28.5K 0.12% 101
2023
Q1
$549K Buy
2,271
+577
+34% +$142K 0.14% 92
2022
Q4
$445K Buy
1,694
+265
+19% +$71K 0.13% 97
2022
Q3
$322K Buy
1,429
+213
+18% +$51.6K 0.11% 110
2022
Q2
$296K Buy
+1,216
New +$298K 0.1% 121

Other funds holding AMGN

Thrive Wealth Management's AMGN Position: Q3 2026 in Review

Thrive Wealth Management reduced its Amgen (AMGN) stake by 16% in Q3 2026, selling an estimated $200K and leaving 2,717 shares worth $1.15M. The position accounts for 0.14% of the portfolio, ranked #76.

Thrive Wealth Management first reported a position in AMGN in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.17M in Q2 2026. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Thrive Wealth Management held 2,717 shares of Amgen worth $1.15M as of Q3 2026.
  • Thrive Wealth Management sold 501 Amgen shares in Q3 2026, an estimated $200K.
  • Amgen made up 0.14% of Thrive Wealth Management's portfolio in Q3 2026, its #76 holding.
  • Thrive Wealth Management first reported a position in Amgen in Q2 2022 and has held it in 18 quarters since.
  • Thrive Wealth Management's Amgen position peaked at $1.17M in Q2 2026.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Thrive Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.